Approval for itrel 4 neurostimulators, models 37703 and 37704.  The devices, as modified, will be marketed under the trade names itrel 4 neurostimulators, models 37703 and 37704 and are indicated as an aid in the management of chronic, intractable pain ofthe trunk and/or limbs-including unilateral or bilateral pain associated with the following conditions:  1) failed back syndrome (fbs) or low back syndrome or failed back; 2) radicular pain syndrome or radiculopathies resulting in pain secondary to fbs or herniated disk; 3)  postlaminectomy pain; 4) multiple back operations; 5) unsuccessful disk surgery; 6)  degenerative disk disease (ddd)/herniated disk pain refractory to conservative and surgical interventions; 7) peripheral causalgia; 8) epidural fibrosis; 9) arachnoiditis or lumbar adhesive arachnoiditis; 10) complex regional pain syndrome (crps);11) reflex sympathetic dystrophy (rsd), or 11) causalgia.